Schneid Yair 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-26 4:45 pm Sale |
2024-09-23 | 13G | ReShape Lifesciences Inc. RSLS |
Schneid Yair | 1,496 8.374% |
-201 (-11.84%) |
Filing |
| 2024-01-16 6:07 pm Purchase |
2024-01-05 | 13G | ReShape Lifesciences Inc. RSLS |
Schneid Yair | 1,697 10.525% |
1,697 (New Position) |
Filing |